COSMO Pharmaceuticals N.V.'s market cap is currently CHF1.14B. The company's EPS TTM is CHF-0.118; its P/E ratio is 20.86; and it has a dividend yield of 2.82%. COSMO Pharmaceuticals N.V. is scheduled to report earnings on July 23, 2025, and the estimated EPS forecast is CHF―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in EUR
COSMO Pharmaceuticals N.V. Earnings and Revenue History
